{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:27:48Z","timestamp":1793834868905,"version":"4.6.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejphar.2026.179244","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:27:31Z","timestamp":1787066851000},"page":"179244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structure-optimized asymmetric siRNA increases predicted AGO2 binding affinity to augment targeted MMP7 gene silencing efficacy"],"prefix":"10.1016","volume":"1032","author":[{"given":"Shixu","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-8872","authenticated-orcid":false,"given":"Zhaoqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179244_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jcph.2337","article-title":"Pharmacokinetics and pharmacodynamics of GalNAc-Conjugated siRNAs","volume":"64","author":"An","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179244_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4939-9220-1_4","article-title":"Relative quantification of siRNA Strand loading into Ago2 for design of highly active siRNAs","author":"Angart","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae577","article-title":"OligoFormer: an accurate and robust prediction method for siRNA design","volume":"40","author":"Bai","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2026.179244_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/nar\/gky1239","article-title":"Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo","volume":"47","author":"Biscans","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120835","article-title":"Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer","volume":"605","author":"Chadar","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejphar.2026.179244_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1208\/s12249-023-02629-1","article-title":"siRNA-Based novel therapeutic strategies to improve effectiveness of antivirals: an Insight","volume":"24","author":"Chatterjee","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejphar.2026.179244_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24020956","article-title":"Structural modifications of siRNA improve its performance in vivo","volume":"24","author":"Chernikov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179244_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf479","article-title":"Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacy","volume":"53","author":"Davis","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib10","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.2174\/0113816128275065231103063935","article-title":"An In-silico approach to design and validate siRNA against Monkeypox virus","volume":"29","author":"Dhotre","year":"2023","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2026.179244_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/hematology.2024000663","article-title":"Givosiran: a targeted treatment for acute intermittent porphyria","author":"Dickey","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ejphar.2026.179244_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196412","article-title":"Cheminformatics modeling of gene silencing for both natural and chemically modified siRNAs","volume":"27","author":"Dong","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.179244_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2026.179244_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12915-020-00803-6","article-title":"Modified nucleic acids: replication, evolution, and next-generation therapeutics","volume":"18","author":"Duffy","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083456","article-title":"Recent update on siRNA therapeutics","volume":"26","author":"Ebenezer","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179244_bib16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1021\/acs.accounts.8b00650","article-title":"Re-Engineering RNA molecules into therapeutic agents","volume":"52","author":"Egli","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymeth.2018.05.010","article-title":"Evaluating the susceptibility of AGO2-loaded microRNAs to degradation by nucleases in vitro","volume":"152","author":"Elbarbary","year":"2019","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2026.179244_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cgt.2016.4","article-title":"Precise and efficient siRNA design: a key point in competent gene silencing","volume":"23","author":"Fakhr","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejphar.2026.179244_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad676","article-title":"PhasiHunter: a robust phased siRNA regulatory cascade mining tool based on multiple reference sequences","volume":"39","author":"Feng","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2026.179244_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048057","article-title":"DSIR: assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes","volume":"7","author":"Filhol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179244_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with Cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179244_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: State-of-the-Art and future perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejphar.2026.179244_bib23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179244_bib24","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179244_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molmed.2023.10.005","article-title":"Three 'E' challenges for siRNA drug development","volume":"30","author":"Guo","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179244_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-025-06359-y","article-title":"CMsiRNAdb: a database of chemically modified SiRNA silencing efficiency for nucleic acid drug design","author":"He","year":"2026","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejphar.2026.179244_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/BJ20140407","article-title":"Effect of the guide strand 3'-end structure on the gene-silencing potency of asymmetric siRNA","volume":"461","author":"Hong","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2026.179244_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179244_bib29","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1007\/s11033-023-08749-y","article-title":"Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities","volume":"50","author":"Isazadeh","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2026.179244_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molcel.2021.11.026","article-title":"Life of RISC: formation, action, and degradation of RNA-induced silencing complex","volume":"82","author":"Iwakawa","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2026.179244_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41587-023-02105-y","article-title":"RNA interference in the era of nucleic acid therapeutics","volume":"42","author":"Jadhav","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2026.179244_bib32","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1038\/mtna.2011.4","article-title":"siRNA-optimized modifications for enhanced in vivo activity","volume":"1","author":"Kenski","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2026.179244_bib33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/17425247.2023.2251890","article-title":"siRNA therapeutics: insights, challenges, remedies and future prospects","volume":"20","author":"Khan","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejphar.2026.179244_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/nat.2023.0003","article-title":"Development of long asymmetric siRNA structure for target gene silencing and immune stimulation in Mammalian cells","volume":"33","author":"Kim","year":"2023","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.ejphar.2026.179244_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-0716-1298-9_2","article-title":"Selection of chemical modifications in the siRNA seed Region that repress off-target effect","volume":"2282","author":"Kobayashi","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1261\/rna.2150806","article-title":"Small interfering RNAs containing full 2'-O-methylribonucleotide-modified sense strands display Argonaute2\/eIF2C2-dependent activity","volume":"12","author":"Kraynack","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.ejphar.2026.179244_bib37","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2026.179244_bib38","article-title":"Structure and stability of Ago2 MID-Nucleotide complexes: All-in-One (Drop) His(6)-SUMO Tag Removal, nucleotide binding, and crystal growth","volume":"4","author":"Lei","year":"2024","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.ejphar.2026.179244_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4441","article-title":"HDOCK update for modeling protein-RNA\/DNA complex structures","volume":"31","author":"Li","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejphar.2026.179244_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117825","article-title":"Advances in structural-guided modifications of siRNA","volume":"110","author":"Li","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179244_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10409238.2020.1738331","article-title":"AGO2 and its partners: a silencing complex, a chromatin modulator, and new features","volume":"55","author":"Li","year":"2020","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41422-025-01114-7","article-title":"Mechanistic insights into RNA cleavage by human Argonaute2-siRNA complex","volume":"35","author":"Li","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bpc.2018.12.006","article-title":"Contribution of 3'T and 3'TT overhangs to the thermodynamic stability of model siRNA duplexes","volume":"246","author":"Lisowiec-Wachnicka","year":"2019","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ejphar.2026.179244_bib44","article-title":"Reconsideration of in-silico siRNA design based on feature selection: a cross-platform data integration perspective","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179244_bib46","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2023-12-3","article-title":"Inclisiran for the treatment of hypercholesterolaemia","volume":"13","author":"Marrs","year":"2024","journal-title":"Drugs Context"},{"key":"10.1016\/j.ejphar.2026.179244_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","article-title":"Comparative protein structure modeling of genes and genomes","volume":"29","author":"Marti-Renom","year":"2000","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.ejphar.2026.179244_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115166","article-title":"The structural basis for RNA slicing by human Argonaute2","volume":"44","author":"Mohamed","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.179244_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gene.2015.02.067","article-title":"Soft computing model for optimized siRNA design by identifying off target possibilities using artificial neural network model","volume":"562","author":"Murali","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.ejphar.2026.179244_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/1471-2105-10-392","article-title":"siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect","volume":"10","author":"Naito","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejphar.2026.179244_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1515\/hsz-2017-0329","article-title":"The AGO proteins: an overview","volume":"399","author":"Niaz","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179244_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/nat.2017.0715","article-title":"Journey of siRNA: clinical developments and targeted delivery","volume":"28","author":"Nikam","year":"2018","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.ejphar.2026.179244_bib53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/nat.2014.0494","article-title":"Effect of siRNA with an asymmetric RNA\/dTdT overhang on RNA interference activity","volume":"24","author":"Park","year":"2014","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.ejphar.2026.179244_bib54","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1073\/pnas.85.8.2444","article-title":"Improved tools for biological sequence comparison","volume":"85","author":"Pearson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.179244_bib55","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1093\/nar\/gkq621","article-title":"Solution-state structure of a fully alternately 2'-F\/2'-OMe modified 42-nt dimeric siRNA construct","volume":"38","author":"Podbevsek","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/cr.2016.22","article-title":"saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription","volume":"26","author":"Portnoy","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib57","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/jm050044o","article-title":"Positional effect of chemical modifications on short interference RNA activity in mammalian cells","volume":"48","author":"Prakash","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179244_bib58","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1093\/nar\/gkl464","article-title":"Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification","volume":"34","author":"Puthenveetil","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nmeth.1818","article-title":"HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment","volume":"9","author":"Remmert","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejphar.2026.179244_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4939-3112-5_23","article-title":"Synthetic SiRNA delivery: progress and prospects","volume":"1364","author":"Roberts","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib61","doi-asserted-by":"crossref","first-page":"8694","DOI":"10.1021\/jacs.6b04454","article-title":"Structural analysis of Human Argonaute-2 bound to a modified siRNA guide","volume":"138","author":"Schirle","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2026.179244_bib62","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/15257770.2024.2347499","article-title":"Nucleic acids based integrated macromolecular complexes for SiRNA delivery: recent advancements","volume":"44","author":"Singh","year":"2025","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ejphar.2026.179244_bib64","doi-asserted-by":"crossref","DOI":"10.1088\/0953-8984\/28\/35\/355301","article-title":"Complex band structures of transition metal dichalcogenide monolayers with spin-orbit coupling effects","volume":"28","author":"Szczesniak","year":"2016","journal-title":"J. Phys. Condens. Matter"},{"key":"10.1016\/j.ejphar.2026.179244_bib65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-1-62703-709-9_22","article-title":"Bioinformatics of siRNA design","volume":"1097","author":"Tafer","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib66","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/acs.jctc.9b00546","article-title":"Gene silencing mechanisms revealed by dynamics of guide, target, and duplex binding to argonaute","volume":"16","author":"Tai","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejphar.2026.179244_bib67","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.179244_bib68","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.molcel.2024.06.026","article-title":"The guide-RNA sequence dictates the slicing kinetics and conformational dynamics of the Argonaute silencing complex","volume":"84","author":"Wang","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2026.179244_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa2409368","article-title":"Plozasiran for managing persistent chylomicronemia and pancreatitis risk","volume":"392","author":"Watts","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179244_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028580","article-title":"Improved siRNA\/shRNA functionality by mismatched duplex","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179244_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148330","article-title":"BERT-siRNA: siRNA target prediction based on BERT pre-trained interpretable model","volume":"910","author":"Xu","year":"2024","journal-title":"Gene"},{"key":"10.1016\/j.ejphar.2026.179244_bib72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-022-04790-2","article-title":"Structure of the Dicer-2-R2D2 heterodimer bound to a small RNA duplex","volume":"607","author":"Yamaguchi","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179244_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-0716-0708-4_12","article-title":"Modeling protein-protein or Protein-DNA\/RNA complexes using the HDOCK webserver","volume":"2165","author":"Yan","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib75","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2026.179244_bib74","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179244_bib76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4939-7540-2_11","article-title":"Identifying RISC components using Ago2 immunoprecipitation and mass spectrometry","volume":"1720","author":"Yi","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179244_bib77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3892\/ijo.2012.1691","article-title":"Asymmetric siRNA targeting the bcl-2 gene inhibits the proliferation of cancer cells in vitro and in vivo","volume":"42","author":"Yin","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2026.179244_bib78","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/hum.2011.145","article-title":"Asymmetric siRNA: new strategy to improve specificity and reduce off-target gene expression","volume":"23","author":"Yuan","year":"2012","journal-title":"Hum. Gene Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:00:16Z","timestamp":1788278416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":77,"alternative-id":["S0014299926007260"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179244","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-optimized asymmetric siRNA increases predicted AGO2 binding affinity to augment targeted MMP7 gene silencing efficacy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179244"}}